A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression.
Apr 14, 2014
0
0
With Alex Trebek's recent announcement that his pancreatic cancer is in remission, many people have wondered if this difficult cancer is now easier to treat. Pancreatic cancer remains a major cancer killer, but advances are ...
May 31, 2019
0
4
The spread of malignant cells around the body, known as metastasis, is the leading cause of mortality in women with breast cancer.
Sep 19, 2016
0
291
(HealthDay)—Focal laser ablation (FLA) of low- to intermediate-risk prostate cancer is associated with low morbidity and good oncologic outcomes, according to a study published in the March issue of the Journal of Vascular ...
Apr 12, 2019
0
4
Loyola Medicine and Palos Health are offering a new breast cancer radiation therapy that shortens the treatment time by three weeks, while reducing side effects.
Apr 15, 2019
0
12
Scientists at VCU Massey Cancer Center have uncovered a previously unrecognized relationship between two sets of proteins that operate in tandem to fend off the growth of pancreatic cancer. The findings could provide pivotal ...
Mar 1, 2023
0
38
A study presented at SNM's 58th Annual Meeting may provide a new tool for detection of malignant-stage ovarian cancer. Researchers found that positron emission tomography and computed tomography (PET/CT), which images both ...
Jun 6, 2011
0
0
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health ...
May 18, 2011
1
0
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health ...
Jun 1, 2011
0
0
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA ...
Oct 11, 2011
0
0
